Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells
Oncogene (2008) - Comment
pubmed: 17891169  doi: 10.1038/sj.onc.1210820  issn: 0950-9232  issn: 1476-5594 

V Barbetti, A Gozzini, E Rovida, A Morandi, E Spinelli, G Fossati, P Mascagni, M Lübbert, P Dello Sbarba, V Santini